Binge eating disorder is characterized by recurrent episodes of consuming large amounts of food with a feeling of loss of control. It is not followed by inappropriate compensatory behavior, such as self-induced vomiting or laxative abuse. Diagnosis is clinical.
Binge eating disorder affects about 3.5% of women and 2.0% of men in the general population. Unlike bulimia nervosa, binge eating disorder occurs most commonly among obese people and contributes to excessive caloric intake; it may be present in ≥ 30% of patients in some weight reduction programs. Compared with people with anorexia nervosa or bulimia nervosa, those with binge eating disorder are older and more likely to be men.
People with binge eating disorder are usually distressed by it, especially if they are trying to lose weight. Clinical depression and preoccupation with body shape, weight, or both are more common in obese people with binge eating disorder than in obese people who are not binge eaters.
Diagnosis requires binge eating for 2 days/wk for at least 6 mo and a sense of lack of control over eating, according to research criteria in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Text Revision. Other criteria include presence of ≥ 3 of the following:
CBT is the most researched and best supported treatment. IPT and dialectical behavior therapy may also be effective. Both CBT and IPT result in remission rates of ≥ 60%; improvement is usually well-maintained over the long-term. These treatments do not produce significant weight loss in obese patients.
Conventional behavioral weight loss treatment has short-term effectiveness in reducing binge eating, but patients tend to relapse. Antidepressant drugs also have short-term effectiveness in eliminating binge eating, but long-term effectiveness is unknown. Initial results with the appetite-suppressing drug sibutramine are promising.
Last full review/revision July 2008 by Albert J. Stunkard, MD; G. Terence Wilson, PhD
Content last modified November 2013